The Independent’s journalism is supported by our readers. When you purchase through links on our site, we may earn commission.

'Chemical surgery' performed for first time on human embryos

Researchers removed the blood disorder beta-thalassemia

Lydia Smith
Thursday 28 September 2017 15:17
Comments
Researchers performed the experiments on lab-made embryos
Researchers performed the experiments on lab-made embryos

Scientists have carried out "chemical surgery" on human embryos to successfully remove a disease for the first time.

Researchers at Sun Yat-sen University in China used a technique called base editing to reprogramme a fault in a single base in our genetic code.

The experiments were carried out in laboratory-made embryos to remove the disease beta-thalassemia, an inherited blood disorder which can cause weakness, fatigue and lead to abnormal blood clots.

In the study, published in the journal Springer, the authors wrote: “β-Thalassemia is a global health issue, caused by mutations in the HBB gene.

“Among these mutations, HBB −28 (A>G) mutations is one of the three most common mutations in China and Southeast Asia patients with β-thalassemia.

“Correcting this mutation in human embryos may prevent the disease being passed onto future generations and cure anemia.”

The team edited one of the “fundamental building blocks of DNA” - the four bases adenine, cytosine, guanine and thymine (A, C, G and T), the BBC reported.

Combinations of these four bases essentially instruct how the human body works.

The blood disorder beta-thelassemia is caused by a change to a single base in the genetic code.

Using base editing, the researchers changed a G to an A to remove the blood disorder.

Base editing, pioneered by Harvard University Professor David Liu, is a new genome editing technology that allows the irreversible modification of genes within organisms.

He described the process as “chemical surgery”.

Register for free to continue reading

Registration is a free and easy way to support our truly independent journalism

By registering, you will also enjoy limited access to Premium articles, exclusive newsletters, commenting, and virtual events with our leading journalists

Please enter a valid email
Please enter a valid email
Must be at least 6 characters, include an upper and lower case character and a number
Must be at least 6 characters, include an upper and lower case character and a number
Must be at least 6 characters, include an upper and lower case character and a number
Please enter your first name
Special characters aren’t allowed
Please enter a name between 1 and 40 characters
Please enter your last name
Special characters aren’t allowed
Please enter a name between 1 and 40 characters
You must be over 18 years old to register
You must be over 18 years old to register
Opt-out-policy
You can opt-out at any time by signing in to your account to manage your preferences. Each email has a link to unsubscribe.

Already have an account? sign in

By clicking ‘Register’ you confirm that your data has been entered correctly and you have read and agree to our Terms of use, Cookie policy and Privacy notice.

This site is protected by reCAPTCHA and the Google Privacy policy and Terms of service apply.

Join our new commenting forum

Join thought-provoking conversations, follow other Independent readers and see their replies

Comments

Thank you for registering

Please refresh the page or navigate to another page on the site to be automatically logged in